[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100309701":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":35,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Herlev Hospital","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Julia Sidenius Johansen, MD, DMsc","CONTACT","+45 38689241","Julia.Sidenius.Johansen@regionh.dk",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Inna Markovna Chen, MD","+45 38682898","Inna.Chen@regionh.dk",[19],{"facility":20,"status":21,"city":22,"state":7,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"Herlev & Gentofte Hospital","RECRUITING","Herlev","2730","Denmark","DK",{"type":27,"coordinates":28},"Point",[29,30],12.43998,55.72366,{"lat":30,"lon":29},[33,34],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Inna Chen, MD","MD","100309701","biomarkers-in-patients-with-pancreatic-cancer-biopac-100309701",false,"NCT03311776","BIOmarkers in Patients With Pancreatic Cancer (\"BIOPAC\")","BIOmarkers in Patients With PAncreatic Cancer (BIOPAC) - Can They Provide New Information of the Disease and Improve Diagnosis and Prognosis of the Patients?","BIOPAC","Inclusion Criteria:\n\n* Age \\> 18 years\n* Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage\n\nExclusion Criteria:\n\n• None","ALL","19 Years",{"count":50,"type":51},5000,"ESTIMATED","OBSERVATIONAL","No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.",[55],"Pancreatic Cancer",[57,58,59,60,61,62],"Pancreatic cancer","Biomarkers","Biobank","Diagnostic biomarkers","Predictive biomarkers","Prognostic biomarkers","2023-02-28",{"date":65,"type":66},"2023-03-01","ACTUAL",{"date":68,"type":66},"2008-07-03",{"date":70,"type":51},"2035-07-02",{"name":37,"class":6},1]